Correction to Faron´s Annual Report 2019
Faron Pharmaceuticals Oy ("Faron" or the "Company") Correction to Faron´s Annual Report 2019 Company announcement, 26 March 2020 at 12.00 PM (EET) TURKU - FINLAND - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces the correction to the Annual Report 2019 which has been published yesterday. The correction is related to the average number of shares and EPS (loss per share). The correct average number of shares is 36,850,577 not 35,533,179 in 2019 as published earlier yesterday in the